Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Min vej til at stoppe med tobak

5. november 2026 opdateret af: University of Wisconsin, Madison

Sammenligning af tre multikomponent-interventioner til at hjælpe voksne med at stoppe med at ryge

The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Primary Objective: Identify the most effective treatment for increasing long-term smoking abstinence among Black adults who smoke.

Secondary Objectives:

  • Compare the 3 interventions on key patient-relevant outcomes (e.g., treatment satisfaction, smoke fewer cigarettes per day, quality of life) using validated measures collected at 8 and 26 weeks post-target quit day (TQD)
  • Identify subgroups for whom these treatments are especially effective or ineffective with respect to the primary and secondary outcomes.
  • Compare indices of treatment engagement (e.g., percentage of counseling sessions attended, percentage of days used nicotine patch) among Black people who smoke and are randomly assigned to the 3 different treatment conditions.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

1550

Fase

  • Fase 4

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

    • Arizona
      • Phoenix, Arizona, Forenede Stater, 85004
        • Ikke rekrutterer endnu
        • Arizona State University
    • Indiana
      • Indianapolis, Indiana, Forenede Stater, 46202
        • Ikke rekrutterer endnu
        • Indiana University
    • Kansas
      • Kansas City, Kansas, Forenede Stater, 66160
        • Ikke rekrutterer endnu
        • University of Kansas Medical Center Research Institute, Inc
    • Virginia
      • Richmond, Virginia, Forenede Stater, 23298
        • Ikke rekrutterer endnu
        • Virginia Commonwealth University
    • Wisconsin
      • Milwaukee, Wisconsin, Forenede Stater, 53233
        • Rekruttering
        • UW School of Medicine and Public Health

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

21 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • self-identify as Black
  • smoke cigarettes (greater than or equal to 1 cigarette on greater than or equal to 4 days/week)
  • motivated to quit smoking
  • willing to discontinue any non-study smoking cessation pharmacotherapy use during study treatment.

Exclusion Criteria:

  • currently taking bupropion for non-smoking cessation reasons

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Standard Intervention

The Standard Intervention will include 2 weeks of nicotine patches + 4 quitline-style counseling phone calls.

Patch dosing will be consistent with the package insert

Andre navne:
  • NicoDerm CQ

4, 10 to 15-minute counseling sessions (the duration of a typical quitline call) will occur via phone one week prior to the TQD, 1 day after the TQD, and 1 and 2 weeks after the TQD.

Eksperimentel: Intensive Intervention

The Intensive Intervention will include 8 weeks of nicotine patches (if eligible) + 8 counseling sessions (choice of individual phone or virtual group) + the Pathways to Freedom video content on the study website with additional smoking cessation content.

Patch dosing will be consistent with the package insert

Andre navne:
  • NicoDerm CQ

Participants will have the option of choosing 8, 30-minute counseling phone calls or 8, 60-minute video group counseling sessions

Pathways to Freedom video content, a 60-minute video that addresses key issues such as emotional dependence, nicotine replacement, identifying smoking triggers, developing coping skills, and other behavioral strategies people can use to support a quit attempt.

Eksperimentel: Intensive Incentivized Intervention

The Intensive Incentivized Intervention will include all components provided in the Intensive intervention (8 weeks of nicotine patches (if eligible) + 8 counseling sessions (choice of individual phone or virtual group) + the Pathways to Freedom video content on the study website with additional smoking cessation content) and up to $50 for completing counseling sessions ($5 for completing sessions 1-6 and $10 for completing sessions 7 and 8)

Patch dosing will be consistent with the package insert

Andre navne:
  • NicoDerm CQ

Participants will have the option of choosing 8, 30-minute counseling phone calls or 8, 60-minute video group counseling sessions

Pathways to Freedom video content, a 60-minute video that addresses key issues such as emotional dependence, nicotine replacement, identifying smoking triggers, developing coping skills, and other behavioral strategies people can use to support a quit attempt.

up to $50 for completing counseling sessions ($5 for completing sessions 1-6 and $10 for completing sessions 7 and 8)

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day
Tidsramme: 26 weeks post-TQD

The primary outcome for this study will be biochemically confirmed (anabasine less than 2 ng/ml) 7-day point-prevalence smoking abstinence at 26- weeks post-TQD

26 weeks post-TQD

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Penge brugt på cigaretter pr. uge
Tidsramme: baseline, 8 og 26 uger efter TQD
baseline, 8 og 26 uger efter TQD
Biochemically confirmed abstinence from any nicotine product at 26-weeks post-target quit day
Tidsramme: 26 weeks post-TQD

salivary cotinine using a cut-off of less than 10 ng/ml to indicate abstinence from any nicotine product (combusted cigarettes, e-cigarettes, nicotine replacement therapy [NRT])

26 weeks post-TQD
Treatment Satisfaction
Tidsramme: 8 weeks post-TQD

Scored from 1 to 7 where higher scores indicate increased satisfaction with treatment.

8 weeks post-TQD
Cigarettes per day
Tidsramme: baseline, 8 and 26 weeks post-TQD

Cigarettes per day based on the past 7 days.

baseline, 8 and 26 weeks post-TQD
Quality of Life measured by the Medical Outcomes Study's 12-item Short Form Survey Instrument (SF-12)
Tidsramme: baseline, 8 and 26 weeks post-TQD

Scores range from 0 to 100 where higher scores indicate better quality of life.

baseline, 8 and 26 weeks post-TQD
Smoking Cessation Self-efficacy using a single 10-point Likert scale
Tidsramme: baseline, 8 and 26 weeks post-TQD

Scores range from 1 to 10 where higher scores mean higher cessation self-efficacy.

baseline, 8 and 26 weeks post-TQD
Psychological Distress measured by the 6-item Kessler screener (K6)
Tidsramme: baseline, 8 and 26 weeks post-TQD

Total range of scores is from 0-24 where higher scores mean decreased psychological distress.

baseline, 8 and 26 weeks post-TQD

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Megan Piper, PhD, UW School of Medicine and Public Health

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

6. juli 2026

Primær færdiggørelse (Anslået)

1. januar 2030

Studieafslutning (Anslået)

1. januar 2030

Datoer for studieregistrering

Først indsendt

11. februar 2026

Først indsendt, der opfyldte QC-kriterier

11. februar 2026

Først opslået (Faktiske)

19. februar 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

10. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

5. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 2025-1697
  • SMPH / CTRI (Anden identifikator: UW Madison)
  • BPS-2024C1-36762 (Andet bevillings-/finansieringsnummer: PCORI)
  • Protocol Version 4/6/26 (Anden identifikator: UW Madison)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL
  • SAP
  • ICF

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ja

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

produkt fremstillet i og eksporteret fra U.S.A.

Ja

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .